Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation
If discoloration or precipitate appears, discard
Furthermore, GHK-Cu has demonstrated neuroprotective properties and can promote the growth of new neurites, potentially enhancing cognitive function and protecting against age-related decline
They're not the same as FDA-approved drugs
The peptide appears to interact with the dopaminergic and serotonergic systems, which may contribute to its effects on pain perception and mood
US$ 29.64
US$ 20.65
US$ 21.07
US$ 27.05
US$ 23.77
